Prosthetic Heart Valve Market Size, Share, By Type (Biological/Tissue Heart Valves, Mechanical Heart Valves, and Transcatheter Heart Valves), By Application (Hospitals, and Ambulatory Surgery Centres), Industry Analysis, Growth, Trends, and Forecast, 2026-2033
Report ID
MSI-2308
Published
February 3, 2026
Pages
320 Pages
Format
Report Details
Comprehensive Market Analysis And Insights
Prosthetic Heart Valve market size is valued at USD 10.5 billion in 2025 and is projected to reach USD 20.4 billion in 2033, at a CAGR of 8.7% from 2026 to 2033
Market Definition
The prosthetic heart valve is an artificial heart valve. It is a one-way valve implanted into a person's heart to replace a valve which is not functioning properly. Prosthetic heart valves are divided into three broad classes including mechanical heart valves, bioprosthetic tissue valves and transcatheter heart valves.
Market Dynamics
Rising prevalence of heart valve disease is driving the market demand. For instance, more than five million Americans are diagnosed with heart valve disease each year. In the United States, there were 3,046 deaths due to rheumatic valvular heart disease and 24,811 deaths due to non-rheumatic valvular heart disease in 2017. Around 25,000 die due to heart valve disease each year in the United States. Further, regulatory approvals of the advanced prosthetic heart valve is a key driving factor of the market. For instance, Medtronic plc has received CE mark and U.S. Food and Drug Administration (FDA) approval of its new Avalus pericardial aortic surgical valve for the treatment of aortic valve disease. The Avalus valve is proven surgical bioprosthetic valve concepts with added features to enhance clinical performance, helping the contemporary needs of cardiac surgeons, as well as patients for aortic valve replacement. The Avalus valve is designed for implantability, an important factor during complex cases. However, the high cost of transcatheter heart valve device and transcatheter aortic valve replacement (TAVR) procedures might hamper the market growth. For instance, the cost of transcatheter aortic valve replacement (TAVR) device is approximately US$ 32,500 as, and the average cost of TAVR surgical procedure is roughly $60,000. Moreover, increasing investments by companies for prosthetic heart valve would provide lucrative opportunities for the market in the coming years.
Market Segmentation
The global prosthetic heart valve market is mainly classified based on type and application. Type is further segmented into Biological/Tissue Heart Valves, Mechanical Heart Valves, and Transcatheter Heart Valves. By application, the market is divided into Hospitals and Ambulatory Surgery Centres.
Transcatheter Heart Valves was dominating the global prosthetic heart valve market in 2019, owing to the technological development in transcatheter heart valves, the collaboration between companies to develop and market transcatheter heart valves, and commercialization of regulatory approved transcatheter heart valves. For instance, Meril has received the CE approval for its indigenously researched and manufactured TAVR technology, Myval-THV system. The approval catapults Meril Life Sciences to the select list of Global Medtech organizations that market and distribute TAVR in European Union and other international geographies. The Myval is a balloon-expandable tri-leaflet, bovine pericardium THV.
Regional Analysis
Based on geography, the global prosthetic heart valve market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided in the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is segmented into India, China, Japan, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.
North America was dominating the global prosthetic heart valve market in 2019, due to the regulatory approval of prosthetic heart valve, commercialization of technologically advanced prosthetic heart valve, rising investment by the companies and government bodies to develop prosthetic heart valve, and collaboration between companies to develop and market prosthetic heart valve. For instance, Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, collaborated with Strait Access Technologies (SAT), a medical device company focused on innovations for the heart, has developed the world’s first durable and cost-effective transcatheter replacement heart valves with polymeric leaflets.
Competitive landscape
Major players operating in the prosthetic heart valve industry include Abbott, Medtronic Plc, Edwards Lifesciences Corporation, Boston Scientific Corporation, Neovasc Inc., LivaNova Plc, Symetis SA, Cryolife, Inc., Lepu Medical Technology Co., Ltd., and Meril Life Sciences.
The commercialization of technological advanced prosthetic heart valve, the partnership between companies to develop and distribute prosthetic heart valve, rising investment for the research, develop, and market prosthetic heart valve, and regulatory approval of prosthetic heart valve are some of the strategies adopted by the major companies. For instance, on January 30, 2020, Abbott has received CE mark approval for its Tendyne Transcatheter Mitral Valve Implantation (TMVI) system and is approved for use in Europe. It is a life-changing therapy treats significant mitral regurgitation (MR) in patients requiring a heart valve replacement and provides a safe solution for MR patients.
Prosthetic Heart Valve Market Key Segments:
By Type
Biological/Tissue Heart Valves
Mechanical Heart Valves
Transcatheter Heart Valves
By Application
Hospitals
Ambulatory Surgery Centres
Key Global Prosthetic Heart Valve Industry Players
Fluid Management Systems Market Size, Share, Trends, 2033
Fluid Management Systems market size is valued at USD 13.5 billion in 2025 and projected to reach USD 35.9 billion by 2033, growing at a CAGR of 13.0%.
Fluid Management Systems market, Fluid Management Systems Market Size, Fluid Management Systems Market Share, Fluid Management Systems Market Analysis, Fluid Management Systems Market Growth, Fluid Management Systems Market Trends, Fluid Management Systems Market Research Report, Fluid Management Systems Market Forecast, Fluid Management Systems, Fluid Management Systems Market Research, Fluid Management Systems Industry, Fluid Management Systems Industry Report, Fluid Management Systems Market Data, Fluid Management Systems Statistics, Fluid Management Systems Market Statistics, Fluid Management Systems Industry Trends, Fluid Management Systems Market Report, Fluid Management Systems Market Trends, Fluid Management Systems Market News, Fluid Management Systems Forecasts, Fluid Management Systems Market Intelligence Report, Fluid Management Systems market 2033, Fluid Management Systems market outlook, Fluid Management Systems market segmentation, Fluid Management Systems market drivers, Fluid Management Systems market restraints, Fluid Management Systems market opportunities, Fluid Management Systems market CAGR, Fluid Management Systems suppliers, Fluid Management Systems manufacturers, Fluid Management Systems market by region, North America Fluid Management Systems market, Asia Pacific Fluid Management Systems market, Europe Fluid Management Systems market, Fluid Management Systems market competitive landscape, Fluid Management Systems market key players, Fluid Management Systems Disposables and Consumables, Fluid Management Systems Arthroscopy market, Fluid Management Systems Urology and Nephrology market, Fluid Management Systems Hospitals market, Fluid Management Systems Dialysis Centers market.
Global Nanorobotics market size reached USD 8.3 billion in 2025 and is forecast to hit USD 15.5 billion by 2033 at a 8.2% CAGR. Segment and regional data.
Ga 68 DOTATOC market size is valued at USD 100.9 million in 2025 and projected to reach USD 235.9 million by 2033, growing at a CAGR of 11.2%.
Ga 68 DOTATOC market, Ga 68 DOTATOC Market Size, Ga 68 DOTATOC Market Share, Ga 68 DOTATOC Market Analysis, Ga 68 DOTATOC Market Growth, Ga 68 DOTATOC Market Trends, Ga 68 DOTATOC Market Research Report, Ga 68 DOTATOC Market Forecast, Ga 68 DOTATOC, Ga 68 DOTATOC Market Research, Ga 68 DOTATOC Industry, Ga 68 DOTATOC Industry Report, Ga 68 DOTATOC Market Data, Ga 68 DOTATOC Statistics, Ga 68 DOTATOC Market Statistics, Ga 68 DOTATOC Industry Trends, Ga 68 DOTATOC Market Report, Ga 68 DOTATOC Market Trends, Ga 68 DOTATOC Market News, Ga 68 DOTATOC Forecasts, Ga 68 DOTATOC Market Intelligence Report, Ga 68 DOTATOC Market Outlook, Ga 68 DOTATOC Market Segmentation, Ga 68 DOTATOC Market Drivers, Ga 68 DOTATOC Market Restraints, Ga 68 DOTATOC Market Opportunities, Ga 68 DOTATOC Market CAGR, Ga 68 DOTATOC Suppliers, Ga 68 DOTATOC Manufacturers, Ga 68 DOTATOC Market by Region, North America Ga 68 DOTATOC Market, Asia Pacific Ga 68 DOTATOC Market, Europe Ga 68 DOTATOC Market, Ga 68 DOTATOC Market Competitive Landscape, Ga 68 DOTATOC Market Key Players, Ga-68 DOTATOC Ready-to-Use Market, Ga-68 DOTATOC Radiolabeling Kits Market, Gastrointestinal Neuroendocrine Tumor Market, Pancreatic Neuroendocrine Tumor Market, Lung Neuroendocrine Tumor Market, Hospitals and Academic Medical Centers Market, Specialty Nuclear Medicine Centers Market, Diagnostic Imaging Centers Market, Radiopharmacies Market, Oncology Centers Market
Bone Graft Substitutes Market Size, Share, Trends, 2033
Bone Graft Substitutes market to hit $5,275.6M by 2033, growing from $1,004.1M in 2025 at a 6.0% CAGR. Explore top industry trends & insights.
Bone Graft Substitutes market, Bone Graft Substitutes Market Size, Bone Graft Substitutes Market Share, Bone Graft Substitutes Market Analysis, Bone Graft Substitutes Market Growth, Bone Graft Substitutes Market Trends, Bone Graft Substitutes Market Research Report, Bone Graft Substitutes Market Forecast, Bone Graft Substitutes, Bone Graft Substitutes Market Research, Bone Graft Substitutes Industry, Bone Graft Substitutes Industry Report, Bone Graft Substitutes Market Data, Bone Graft Substitutes Statistics, Bone Graft Substitutes Market Statistics, Bone Graft Substitutes Industry Trends, Bone Graft Substitutes Market Report, Bone Graft Substitutes Market Trends, Bone Graft Substitutes Market News, Bone Graft Substitutes Forecasts, Bone Graft Substitutes Market Intelligence Report, Bone Graft Substitutes Market 2033, Bone Graft Substitutes Market Outlook, Bone Graft Substitutes Market Segmentation, Bone Graft Substitutes Market Drivers, Bone Graft Substitutes Market Restraints, Bone Graft Substitutes Market Opportunities, Bone Graft Substitutes Market CAGR, Bone Graft Substitutes Suppliers, Bone Graft Substitutes Manufacturers, Bone Graft Substitutes Market by Region, North America Bone Graft Substitutes Market, Asia Pacific Bone Graft Substitutes Market, Europe Bone Graft Substitutes Market, Bone Graft Substitutes Market Competitive Landscape, Bone Graft Substitutes Market Key Players, Mineralized Bone Allografts Market, Demineralized Bone Matrix Market, Cellular Bone Matrices Market, Synthetic Bone Graft Substitutes Market, Bone Morphogenetic Protein-Based Grafts Market, Spinal Fusion Bone Graft Substitutes, Trauma and Long-Bone Repair Bone Graft Substitutes, Joint Reconstruction Bone Graft Substitutes, Dental Bone Grafting Market.
